Patents by Inventor Nigel Raymond

Nigel Raymond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220305150
    Abstract: A composition comprising including a homogeneous tin-117m colloid comprising tin-117m, and an ascorbic acid is provided, the composition naturally has a white coloration. The composition is visually distinct from a conventional homogeneous tin-117m colloid because conventional colloids have an orange-yellow color. The addition of ascorbic acid changes the color of the composition without adding toxicity and without changing the therapeutic effects of the homogeneous tin-117m colloid. A use and a method of making the same is also provided.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 29, 2022
    Inventors: Nigel Raymond Stevenson, Gilbert R. Gonzales, Jaime Simón
  • Patent number: 9269467
    Abstract: Methods for producing a radioisotope by a charged particle irradiation of a fluid target matrix are provided. A method of producing a radioisotope includes irradiating a fluid target matrix comprising a compound of a target isotope with a charged particle beam to transform at least a portion of the target isotope to the radioisotope, and isolating the radioisotope from the irradiated fluid target matrix. The target isotope may be an isotope of cadmium, an isotope of thallium, an isotope of zinc, an isotope of gallium, an isotope of tellurium, an isotope of molybdenum, an isotope of rhodium, an isotope of selenium, an isotope of nickel, an isotope of yttrium, an isotope of strontium, an isotope of bismuth, an isotope of tungsten, and an isotope of titanium, provided that the target isotope is not Mo-100.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: February 23, 2016
    Inventor: Nigel Raymond Stevenson
  • Patent number: 8632748
    Abstract: Compositions of high specific activity 117mSn with specific activity of greater than 100 Ci/g Sn and methods of producing the same. The method includes exposing 116Cd to an ?-particle beam of sufficient incident kinetic energy and duration to convert a portion of the 116Cd to 117mSn to form an irradiated material. The irradiated material is dissolved to form an intermediate solution containing 117mSn and 116Cd. The 117mSn is separated from the 116Cd to yield high specific activity 117mSn.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: January 21, 2014
    Assignee: Clear Vascular, Inc.
    Inventors: Nigel Raymond Stevenson, Ian Martin Horn
  • Publication number: 20120321558
    Abstract: Compositions of high specific activity 117mSn with specific activity of greater than 100 Ci/g Sn and methods of producing the same. The method includes exposing 116Cd to an ?-particle beam of sufficient incident kinetic energy and duration to convert a portion of the 116Cd to 117mSn to form an irradiated material. The irradiated material is dissolved to form an intermediate solution containing 117mSn and 116Cd. The 117mSn is separated from the 116Cd to yield high specific activity 117mSn.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicant: CLEAR VASCULAR, INC.
    Inventors: Nigel Raymond Stevenson, Ian Martin Horn
  • Publication number: 20120307953
    Abstract: Methods for producing a radioisotope by a charged particle irradiation of a fluid target matrix are provided. A method of producing a radioisotope includes irradiating a fluid target matrix comprising a compound of a target isotope with a charged particle beam to transform at least a portion of the target isotope to the radioisotope, and isolating the radioisotope from the irradiated fluid target matrix. The target isotope may be an isotope of cadmium, an isotope of thallium, an isotope of zinc, an isotope of gallium, an isotope of tellurium, an isotope of molybdenum, an isotope of rhodium, an isotope of selenium, an isotope of nickel, an isotope of yttrium, an isotope of strontium, an isotope of bismuth, an isotope of tungsten, and an isotope of titanium, provided that the target isotope is not Mo-100.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 6, 2012
    Inventor: Nigel Raymond Stevenson
  • Patent number: 8257681
    Abstract: Compositions of high specific activity 117mSn with specific activity of greater than 100 Ci/g Sn and methods of producing the same. The method includes exposing 116Cd to an ?-particle beam of sufficient incident kinetic energy and duration to convert a portion of the 116Cd to 117mSn to form an irradiated material. The irradiated material is dissolved to form an intermediate solution containing 117mSn and 116Cd. The 117mSn is separated from the 116Cd to yield high specific activity 117mSn.
    Type: Grant
    Filed: December 26, 2008
    Date of Patent: September 4, 2012
    Assignee: Clear Vascular Inc.
    Inventors: Nigel Raymond Stevenson, Ian Martin Horn
  • Publication number: 20100166653
    Abstract: Compositions of high specific activity 117mSn with specific activity of greater than 100 Ci/g Sn and methods of producing the same. The method includes exposing 116Cd to an ?-particle beam of sufficient incident kinetic energy and duration to convert a portion of the 116Cd to 117mSn to form an irradiated material. The irradiated material is dissolved to form an intermediate solution containing 117mSn and 116Cd. The 117mSn is separated from the 116Cd to yield high specific activity 117mSn.
    Type: Application
    Filed: December 26, 2008
    Publication date: July 1, 2010
    Applicant: CLEAR VASCULAR, INC.
    Inventors: Nigel Raymond Stevenson, Ian Martin Horn
  • Patent number: 6472518
    Abstract: Genes isolated from Neisseria memingitidis, as well as isolated nucleic acids, probes, expression cassettes, polypeptides, antibodies, immunogenic compositions, antisense nucleic acids, amplification mixtures, and new invasion deficient swains of Neisseria meningitidis are provided Methods of detecting Neisseria meningitidis and Neisseria meningitidis nucleic acids, and methods of inhibiting the invasion of mammalian cells by Neisseria meningitidis are also provided.
    Type: Grant
    Filed: August 17, 1999
    Date of Patent: October 29, 2002
    Assignee: Centers for Disease Control and Prevention, as represented by the Secretary, Department of Health and Human Services
    Inventors: Efrain M. Ribot, David S. Stephens, Nigel Raymond, Frederick D. Quinn
  • Patent number: D560467
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: January 29, 2008
    Assignee: Trellicor (Proprietary) Limited
    Inventor: Nigel Raymond Pattison